These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Treatment of cognitive impairment in patients with multiple sclerosis. Patti F Expert Opin Investig Drugs; 2012 Nov; 21(11):1679-99. PubMed ID: 22876911 [TBL] [Abstract][Full Text] [Related]
12. Cognitive deficits in multiple sclerosis: correlations with T2 changes in normal appearing brain tissue. Lund H; Jønsson A; Andresen J; Rostrup E; Paulson OB; Sørensen PS Acta Neurol Scand; 2012 May; 125(5):338-44. PubMed ID: 21793807 [TBL] [Abstract][Full Text] [Related]
13. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G; Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262 [TBL] [Abstract][Full Text] [Related]
14. MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction. Rovaris M; Comi G; Filippi M J Neurol Sci; 2006 Jun; 245(1-2):111-6. PubMed ID: 16626748 [TBL] [Abstract][Full Text] [Related]
15. Cognitive impairment and structural brain damage in benign multiple sclerosis. Rovaris M; Riccitelli G; Judica E; Possa F; Caputo D; Ghezzi A; Bertolotto A; Capra R; Falautano M; Mattioli F; Martinelli V; Comi G; Filippi M Neurology; 2008 Nov; 71(19):1521-6. PubMed ID: 18815387 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients. Benedict RH; Hulst HE; Bergsland N; Schoonheim MM; Dwyer MG; Weinstock-Guttman B; Geurts JJ; Zivadinov R Mult Scler; 2013 Oct; 19(11):1478-84. PubMed ID: 23459570 [TBL] [Abstract][Full Text] [Related]
18. Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management. Bagert B; Camplair P; Bourdette D CNS Drugs; 2002; 16(7):445-55. PubMed ID: 12056920 [TBL] [Abstract][Full Text] [Related]
19. The association between cognitive impairment and quality of life in patients with early multiple sclerosis. Glanz BI; Healy BC; Rintell DJ; Jaffin SK; Bakshi R; Weiner HL J Neurol Sci; 2010 Mar; 290(1-2):75-9. PubMed ID: 19944429 [TBL] [Abstract][Full Text] [Related]
20. Anticholinesterasics in the treatment of cognitive impairment in multiple sclerosis. Porcel J; Montalban X J Neurol Sci; 2006 Jun; 245(1-2):177-81. PubMed ID: 16674980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]